India Biologics Market Overview

Base Year: 2023

Historical Years: 2018-2023

Forecast Years: 2024-2032

Market Growth Rate: 8.20% (2024-2032)

The India biologics market is expanding rapidly, driven by demand for advanced therapeutics, government support, and rising healthcare investments. According to the latest report by IMARC Group, the market is projected to grow at a CAGR of 8.20% from 2024 to 2032.

India Biologics Market Trends and Drivers:

The India biologics market is expanding rapidly, owing to several interconnected factors, such as the rising healthcare demands, more investments, and technical improvements. Primarily, the increasing need for biologic medications, which provide focused treatments for long-term illnesses like diabetes, cancer, and autoimmune disorders, is a major driver of this expansion.

Meanwhile, as more individuals are diagnosed with these conditions, the demand for effective biologic treatments has soared. Additionally, several initiatives of the government bodies aimed at improving wellness infrastructure, along with rising healthcare expenditures, are supporting the development of the India biologics market. In line with these factors, the entry of various pharmaceutical companies, both domestic and international, into the biologics space has further boosted the production and development of new biologics across India.

The adoption of biosimilars, which are cost-effective alternatives to biological drugs, is emerging as a key trend in the India biologics market. Furthermore, biosimilars are gaining popularity due to their affordability compared to traditional biologics, making advanced therapies accessible to a larger population. This trend is amplified by regulatory support from Indian authorities, which is encouraging the development and approval of biosimilars.

Additionally, advancements in biomanufacturing techniques, such as cell culture and recombinant DNA technology, are improving the efficiency and scalability of biologic production. Apart from this, these trends are anticipated to continue driving the growth, providing new avenues for innovation and patient care in the country. Consequently, the convergence of these factors is anticipated to propel the expansion of the India biologics market in the coming years.

Request for a sample copy of this report: https://www.imarcgroup.com/india-biologics-market/requestsample

India Biologics Market Industry Segmentation:

The report has segmented the market into the following categories:

Breakup by Source:

• Microbial
• Mammalian
• Others

Breakup by Product:

• Monoclonal Antibodies
• Vaccines
• Recombinant Proteins
• Antisense, RNAi and Molecular Therapy
• Others

Breakup by Disease:

• Oncology
• Immunological Disorders
• Cardiovascular Disorders
• Hematological Disorders
• Others

Breakup by Manufacturing:

• Outsourced
• In-House

Breakup by Region:

• North India
• West and Central India
• South India
• East and Northeast India

Competitive Landscape:

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=21849&flag=C

Key highlights of the Report:

• Market Performance (2018-2023)
• Market Outlook (2024-2032)
• COVID-19 Impact on the Market
• Porter’s Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.

IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:  

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: sales@imarcgroup.com 

Tel No:(D) +91 120 433 0800 

United States: +1-631-791-1145

• Uncategorized